Upgrade IA Capital Markets analyst Chelsea Stellick raised her Quipt Home Medical Corp. (QIPT-X) target to $13.50 from $13.25, topping the $12.16 average, with a “buy” rating.
“QIPT continues to expand through M&A to build out a national DME platform, and recent momentum is in line with management’s commentary and our call for a larger acquisition by year end. These three acquisitions unambiguously create value and reinforce the value creation that make QIPT our top pick,” she said.